US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silexion Therapeutics Corp

0.8856

-0.0262-2.87%

Post-market: 0.8773-0.0083-0.94%19:50 EDT

Volume:223.49K

Turnover:199.61K

Market Cap:7.70M

PE:-6.56

High:0.9299

Open:0.9200

Low:0.8800

Close:0.9118

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Silexion Therapeutics Corp. Appeals Nasdaq Delisting Notice; Securities Continue Trading Pending Hearing

Silexion Therapeutics Announces Promising Preclinical Results for SIL204, Targeting KRAS-Driven Cancers

Silexion Therapeutics announces preclinical results on SIL204

Silexion Therapeutics Announces Groundbreaking Preclinical Results: Sil204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SLXN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":0.8856,"timestamp":1749758400000,"preClose":0.9118,"halted":0,"volume":223490,"hourTrading":{"tag":"盘后","latestPrice":0.8773,"preClose":0.8856,"latestTime":"19:50 EDT","volume":8806,"amount":7749.87734,"timestamp":1749772214460},"delay":0,"floatShares":5231700,"shares":8692392,"eps":-0.135024,"marketStatus":"Closed","change":-0.0262,"latestTime":"06-12 16:00:00 EDT","open":0.92,"high":0.9299,"low":0.88,"amount":199611.9797556,"amplitude":0.054727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.135024,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749801600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9118,"preHourTrading":{"tag":"盘前","latestPrice":0.91,"preClose":0.9118,"latestTime":"09:26 EDT","volume":489,"amount":445.0850127,"timestamp":1749734793709},"postHourTrading":{"tag":"盘后","latestPrice":0.8773,"preClose":0.8856,"latestTime":"19:50 EDT","volume":8806,"amount":7749.87734,"timestamp":1749772214460},"volumeRatio":0.988491},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":5231700,"roa":"-193.54%","roe":"--","lyrEps":0.042916,"volumeRatio":0.988491,"shares":8692392,"dividePrice":0,"high":0.9299,"amplitude":0.054727,"preClose":0.9118,"low":0.88,"week52Low":0.575,"pbRate":"-1.93","week52High":122.0184,"institutionHeld":0,"latestPrice":0.8856,"eps":-0.135024,"divideRate":0,"volume":223490,"delay":0,"ttmEps":-0.135024,"open":0.92,"prevYearClose":2.01,"prevWeekClose":0.9458,"prevMonthClose":1.04,"prevQuarterClose":1.1,"fiveDayClose":0.9215,"twentyDayClose":0.9605,"sixtyDayClose":1.25},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SLXN\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLXN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540570417","title":"Silexion Therapeutics Corp. Appeals Nasdaq Delisting Notice; Securities Continue Trading Pending Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540570417","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540570417?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:06","pubTimestamp":1748981190,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics Corp., a Cayman Islands-based company, is currently facing a delisting process from the Nasdaq Global Market due to non-compliance with required market value standards. The company received a delisting notice after failing to rectify these deficiencies by the designated deadline of May 19, 2025. In response, Silexion has requested a hearing to appeal the delisting notice, which has temporarily stayed the process and allowed its securities to continue trading under the symbols \"SLXN\" and \"SLXNW.\" As part of its strategy, Silexion plans to apply for a transfer of its listing to the Nasdaq Capital Market. The hearing date has not been specified, but the appeal process allows continued trading until the hearing occurs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL8DbGSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLXN","BK4139"],"gpt_icon":0},{"id":"2539660172","title":"Silexion Therapeutics Announces Promising Preclinical Results for SIL204, Targeting KRAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2539660172","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539660172?lang=en_us&edition=fundamental","pubTime":"2025-05-29 22:15","pubTimestamp":1748528107,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics Corp., a clinical-stage biotechnology company specializing in RNA interference  therapies for KRAS-driven cancers, has announced noteworthy preclinical results for its therapeutic candidate, SIL204. The data demonstrates SIL204's efficacy in inhibiting tumor proliferation across pancreatic, colorectal, and lung cancer cell lines, each harboring the KRAS G12D mutation. The study revealed a significant inhibition rate of approximately 90% in GP2D human colorectal cancer cells. SIL204 utilizes a lipid-conjugated delivery system to enhance the uptake and concentration of small interfering RNA  within cells, showing potential for low-dose effectiveness. These findings suggest expanded therapeutic applications for SIL204, with Silexion planning further preclinical studies focused on lung cancer cell lines. The company's RNAi approach addresses a substantial unmet medical need in treating KRAS-driven cancers, which represent a large market with limited current treatment ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL6v8DZb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLXN","BK4139"],"gpt_icon":0},{"id":"2539632562","title":"Silexion Therapeutics announces preclinical results on SIL204","url":"https://stock-news.laohu8.com/highlight/detail?id=2539632562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539632562?lang=en_us&edition=fundamental","pubTime":"2025-05-29 21:10","pubTimestamp":1748524221,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics (SLXN) announced compelling preclinical data demonstrating the efficacy of its next-generation RNAi therapeutic candidate, SI...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/silexion-therapeutics-announces-preclinical-results-on-sil204-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/silexion-therapeutics-announces-preclinical-results-on-sil204-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","SLXN","BK4139","BK4007"],"gpt_icon":0},{"id":"2539638792","title":"Silexion Therapeutics Announces Groundbreaking Preclinical Results: Sil204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2539638792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539638792?lang=en_us&edition=fundamental","pubTime":"2025-05-29 21:05","pubTimestamp":1748523900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nTUA6QDD9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLXN","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1730520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLXN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLXN","date":"2025-06-11","current":-0.48104,"percent":0.709677,"low":-0.532214,"twenty":-0.51067,"median":-0.492426,"eighty":-0.477713,"high":-0.46057,"avg":-0.493437,"sd":0.019118,"marketCap":7909738},"quantilePoints":[{"date":"2025-05-02","current":-0.511745,"twenty":-0.505522,"median":-0.478123,"eighty":-0.462658,"marketCap":8414615},{"date":"2025-05-09","current":-0.508623,"twenty":-0.511745,"median":-0.504017,"eighty":-0.475134,"marketCap":8363285},{"date":"2025-05-16","current":-0.49368,"twenty":-0.511295,"median":-0.503966,"eighty":-0.488849,"marketCap":8117579},{"date":"2025-05-23","current":-0.504427,"twenty":-0.509135,"median":-0.49826,"eighty":-0.470682,"marketCap":8294286},{"date":"2025-05-30","current":-0.491275,"twenty":-0.511407,"median":-0.49826,"eighty":-0.475032,"marketCap":8078030},{"date":"2025-06-06","current":-0.471573,"twenty":-0.511407,"median":-0.49368,"eighty":-0.475196,"marketCap":7754067},{"date":"2025-06-11","current":-0.48104,"twenty":-0.51067,"median":-0.492426,"eighty":-0.477713,"marketCap":7909738}],"updateTime":1749778965013}}}